ArticleFrontiers in public health2025
Higher everyday functioning, lower quality of life, and home care are associated with persisting symptoms after a COVID-19 infection in German care recipients.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To date, risk factors for persisting symptoms after a COVID-19 infection have not been investigated in people needing care or support. Prior meta-analyses identified age, obesity, and female sex as risk factors for persisting symptoms after a COVID-19 infection in the general population. Methods: This study is part of the Bavarian ambulatory COVID-19 monitor. Data were collected from ambulatory patients needing care/support and a past COVID-19 infection. Different exposure measures (age, sex, body-mass index, income, packyears, smoker status, relationship status, type of care, care level, educational and vocational qualification, quality of life, health status, functioning, depression, cognitive abilities, anxiety) and persisting symptoms after COVID-19 (≥ 1 symptom with a duration of ≥12 weeks following a COVID-19 infection) were collected. Bivariate analyses and multiple logistic regression with multiple imputations were used to investigate the association between exposure and persisting symptoms. Results: We included 514 participants (COVID-19 infection, needing care/support, completed questions on persistent symptoms). 68.3% were female, with a mean age of 80.5 years (range: 24-103 years). The sample is characterized by the need for support (i.e., degree of impairment of independence or frailty score ≥ 5). Bivariate analyses revealed associations of everyday functioning, depression, cognitive functioning, living in a relationship, care level, educational qualification, vocational qualification, and type of care with persisting symptoms. In multiple logistic regression, a higher level of functioning (OR = 2.72, 95%-CI: 1.20, 6.17), the quality of life (OR = 1.12, 95%-CI: 1.03, 1.23), and the type of care (OR = 3.16, 95%-CI: 1.48, 6.73) were significantly associated with persisting symptoms. Discussion: This is one of the first studies investigating the risk factors for persisting symptoms after COVID-19 in people in need of care or support. The risk factors in our study (everyday functioning, depression, cognitive functioning, living in a relationship, care level, educational qualification, vocational qualification, and type of care) differ from those identified in prior meta-analyses on the general population (age, obesity, female sex; these were not significant in our study). Our study highlights the importance of considering vulnerable groups in particular from the outset of future pandemic or epidemic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.